Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  DBV Technologies    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
05/19/2020 05/20/2020 05/21/2020 05/22/2020 05/25/2020 Date
8.345(c) 8.495(c) 8.225(c) 8.255(c) 8.17 Last
702 620 600 909 446 363 383 469 212 222 Volume
-16.80% +1.80% -3.18% +0.36% -1.03% Change
More quotes
Financials
Sales 2020 16,8 M 18,3 M 18,3 M
Net income 2020 -174 M -189 M -189 M
Net cash position 2020 96,9 M 106 M 106 M
P/E ratio 2020 -2,26x
Yield 2020 -
Sales 2021 67,5 M 73,6 M 73,6 M
Net income 2021 -138 M -150 M -150 M
Net Debt 2021 11,4 M 12,4 M 12,4 M
P/E ratio 2021 -2,72x
Yield 2021 -
Capitalization 453 M 494 M 494 M
EV / Sales 2020 21,2x
EV / Sales 2021 6,88x
Nbr of Employees 311
Free-Float 76,5%
More Financials
Company
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin. 
Sector
Pharmaceuticals
Calendar
07/24Earnings Release
More about the company
Surperformance© ratings of DBV Technologies
Trading Rating : Investor Rating :
More Ratings
Latest news on DBV TECHNOLOGIES
04/30DBV TECHNOLOGIES : Reports March 31, 2020 Cash Position
GL
04/30DBV TECHNOLOGIES : 1st quarter earnings
CO
04/20DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary Gen..
GL
04/20DBV TECHNOLOGIES : Proxy Statments
CO
04/16DBV TECHNOLOGIES : - Ordinary and Extraordinary General Meeting of April 20, 202..
AQ
04/15DBV TECHNOLOGIES : Ordinary and Extraordinary General Meeting of April 20, 2020
PU
04/13DBV TECHNOLOGIES : - Ordinary and Extraordinary General Meeting of April 20, 202..
AQ
04/10Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Cl..
GL
03/31DBV TECHNOLOGIES : - Ordinary and Extraordinary General Meeting of April 20, 202..
AQ
03/30Ordinary and Extraordinary General Meeting of April 20, 2020
GL
03/23DBV TECHNOLOGIES : Announces Filing of 2019 Universal Registration Document and ..
AQ
03/20DBV TECHNOLOGIES : Annual and transition report of foreign private issuers
PU
03/20DBV TECHNOLOGIES : 20-f
PU
03/20DBV Technologies Announces Filing of 2019 Universal Registration Document and..
GL
03/18DBV TECHNOLOGIES : AGM 2020 – Report of the Board of Directors to the Comb..
PU
More news
News in other languages on DBV TECHNOLOGIES
05/22DBV TECHNOLOGIES : plus forte baisse du SBF 120 à la mi-séance du 22 mai 2020
05/19DBV TECHNOLOGIES : plus forte baisse du SBF 120 à la clôture mardi 19 mai 2020 -
05/19DBV TECHNOLOGIES : plus forte baisse du marché SRD à la clôture mardi 19 mai 202..
05/04EN DIRECT DES MARCHES : Société Générale, Airbus, bioMérieux, Europcar, DBV T..
05/04Les valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 4 mai 2020
More news
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | DBV | FR0010417345 | MarketScreener
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 18,65 €
Last Close Price 8,26 €
Spread / Highest target 272%
Spread / Average Target 126%
Spread / Lowest Target 21,1%
EPS Revisions
Managers
NameTitle
Daniel Tassé Chief Executive Officer & Executive Director
Michel de Rosen Non-Executive Chairman
Ramzi Benamar Chief Financial Officer
Bertrand Dupont Chief Technology Officer
Hugh A. Sampson Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
DBV TECHNOLOGIES-57.95%494
JOHNSON & JOHNSON-1.03%380 356
ROCHE HOLDING AG10.48%303 907
PFIZER, INC.-4.29%208 306
MERCK & CO., INC.-16.03%192 766
NOVARTIS AG-10.58%186 299